MDSC, a heterogeneous population of immune suppressive cells that are produced at high levels in cancer, are defined in mice on the basis of expression of the surface markers CD11b and GR1 and by their ability to inhibit T lymphocyte activation. The gene discussed is ITGAM; the disease is cancer.